Feed PFND
PF
Pathfinder Cell Therapy, Inc.
PFND · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
Asset turnover N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Debt/Assets N/A
Stability
79 /100
Stable Beta 1.07x
Rev. volatility N/A
EPS volatility N/A
Întreabă StockBot despre PFND
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard L. Franklin
Employees
1
Headquarters
Cambridge